| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PED | Common Stock | Sale | -$27.4K | -41.7K | -4.73% | $0.66 | 839K | Jan 19, 2024 | Direct | F1, F2 |
| transaction | PED | Common Stock | Sale | -$37.1K | -58.3K | -6.95% | $0.64 | 780K | Jan 23, 2024 | Direct | F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the January 19, 2024 vesting of certain shares of restricted stock which were granted under the Company's 2012 Equity Incentive Plan, which grants were exempt from Section 16(b) pursuant to Rule 16b-3. |
| F2 | This transaction was executed in multiple trades at prices ranging from $0.6362 to $0.681, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the January 23, 2024 vesting of certain shares of restricted stock which were granted under the Company's 2021 Equity Incentive Plan, which grants were exempt from Section 16(b) pursuant to Rule 16b-3. |
| F4 | This transaction was executed in multiple trades at prices ranging from $0.6293 to $0.65, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
See Power of Attorney filed as Exhibit 24.1 to the Form 4 filed by Reporting Person on January 15, 2020.